Stay updated on Repotrectinib in Rearranged Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.

Latest updates to the Repotrectinib in Rearranged Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history updates reflect a capitalization normalization of the contact information label and the addition of a new revision tag (v3.7.0) to the history, replacing the previous v3.6.6 entry.SummaryDifference0.1%

- Check47 days agoChange DetectedAn additional revision tag, v3.6.6, is added to the history, replacing the previous v3.6.5. This reflects a minor update to the page's versioning metadata rather than changes to study information.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.6.5 is now listed in the history, updating the page to the latest system version and replacing v3.6.4.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page footer's Revision value was updated from v3.6.3 to v3.6.4, indicating a new site release of ClinicalTrials.gov.SummaryDifference0.0%

- Check104 days agoChange DetectedThe page's revision label updated from v3.6.2 to v3.6.3, signaling a new build of the page. This reflects an update to the page rendering rather than substantive study information.SummaryDifference0.0%

Stay in the know with updates to Repotrectinib in Rearranged Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.